PMID: 2407452Mar 1, 1990Paper

Localized leukemic pulmonary infiltrates. Diagnosis by bronchoscopy and resolution with therapy

R KovalskiG G Pietra


Although commonly found at autopsy, leukemic infiltration of the lung is rarely recognized as a cause of respiratory symptoms or roentgenographic densities. Previously reported cases of patients who had symptomatic or roentgenographic acute leukemic lung diseases invariably presented with diffuse pulmonary infiltrates. We describe three patients with leukemic involvement of the lung who presented with cough, fever, and localized roentgenographic infiltrates suggestive of bacterial pneumonia. In each case, the diagnosis was made by transbronchial biopsy specimen and confirmed by complete response to chemotherapy. In common with the other reported cases, all of our patients had peripheral blast counts above 40 percent (greater than 6,000 blasts per ml3) at the time the pulmonary diagnosis was made. Leukemic invasion of the lung should be considered in patients with acute leukemia who develop lung infiltrates--whether diffuse or focal--in association with a high peripheral blast count.


Mar 1, 1979·Chest·G P Bodey
Apr 1, 1977·International Surgery·W MannellaT Matsumoto
Sep 1, 1985·Mayo Clinic Proceedings·W R WilsonE C Rosenow
Jun 1, 1966·Cancer·G P BodeyE J Freireich
Aug 1, 1980·AJR. American Journal of Roentgenology·P ArmstrongM O'Hara
Sep 1, 1980·Chest·M F Tenholder, R G Hooper
May 12, 1955·The New England Journal of Medicine·D J NATHAN, M SANDERS


Dec 19, 2008·International Journal of Hematology·Kazuhiko KakihanaHisashi Sakamaki
Aug 2, 2001·The Journal of Small Animal Practice·T MoriT Fujinaga
Jul 1, 1994·Journal of Veterinary Internal Medicine·V Buechner-MaxwellM J Murray
Feb 8, 2003·American Journal of Respiratory and Critical Care Medicine·Elie AzoulayBenoît Schlemmer
Feb 5, 2000·AJR. American Journal of Roentgenology·L E HeynemanN L Müller
Jun 14, 2006·Journal of Thoracic Imaging·William MooreYoujun Hu
Nov 1, 1990·Chest·F L HildebrandH D Tazelaar
May 22, 2008·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yao-Kuang WuYing-Huang Tsai
Nov 24, 2005·Chest·Dominic J ValentinoAllen H Roberts
Oct 12, 2010·Revue de pneumologie clinique·J-V MalfusonT de Revel
Jul 9, 2010·Revue des maladies respiratoires·Y UzunhanA Bergeron
Oct 18, 2015·Journal of Ethnopharmacology·Ching-Fen WuThomas Efferth
Nov 20, 2012·Diagnostic Cytopathology·Michelle O'LearyPaolo Gattuso
Aug 26, 2010·British Journal of Haematology·Maaike Luesink, Joop H Jansen
Feb 16, 2005·La Revue de médecine interne·F BroussaisD Robert
Aug 30, 2006·Paediatric Respiratory Reviews·Emma McCahon
Apr 27, 2017·The British Journal of Radiology·Anuradha SinghAtin Kumar
Apr 7, 2000·Leukemia & Lymphoma·V MeigninA Janin
Mar 22, 2003·British Journal of Haematology·Leonardo PotenzaGiuseppe Torelli
Jul 1, 1993·Postgraduate Medicine·Harry Staszewski

Related Concepts

Antineoplastic Chemotherapy Protocols
Bronchoalveolar Lavage Fluid
Bronchoscopic Surgical Procedures
Malignant Neoplasm of Lung
Acute Myeloid Leukemia, M1
Acute Myelomonocytic Leukemia
Leukemia, Lymphocytic, Acute, L2

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.